Best Life Sciences Companies in Tucson, United States
The 58 best Life Sciences companies in Tucson, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Accelerate Diagnostics.
Our analysis of 164 Life Sciences companies
$34.7b in tracked funding; 83% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences companies in Tucson
| # | Company | Disclosed funding | Last round | Employees | Founder | Stage | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Accelerate Diagnostics Developer of diagnostic devices and test kits for the antibiotic resistant infections | $366M | 64 mo ago | 197 | — | Public | Cart FunctionalityWordPressMySQL+26 | 90 patents Lens-free holographic imaging for label‑free cellular/microbial detection and susceptibility testing | — |
| 2 | MTM Laboratories In vitro diagnostics with a focus on early detection and diagnosis of cervical cancer | $76M | 188 mo ago | — | Peter Pack Founder & CEO | Acquired | — | — | — |
| 3 | HTG Molecular Diagnostics Developer of diagnostics and targeted therapeutics across a variety of disease areas | $47M | 72 mo ago | 47 | — | Public | Cloudflare Browser InsightsCloudflareHTTP/3 | 94 patents Molecular diagnostics for cancer via epitranscriptomic biomarkers and targeted sequencing | — |
| 4 | Cancer Prevention Pharmaceuticals Your trusted source for health education, tips, and guidance | $16M | 65 mo ago | 14 | Frank Meyskens Co-Founder | Acquired | — | — | — |
| 5 | Calimmune Developer of autologous cell therapies to enhance immune response for infectious diseases | $16M | 133 mo ago | 23 | — | Acquired | — | 72 patents Gene therapy vector platforms for AAV/lentiviral delivery targeting hemoglobinopathies and HIV. | — |
| 6 | Luceome Biotechnologies Develop assay technology for the identification of drugs against kinases | $13M | 51 mo ago | 9 | — | Funding Raised | — | — | — |
| 7 | Valley Fever Solutions Developing innovative antifungal solutions to conquer Valley Fever and fungal diseases | $12M | 144 mo ago | — | David Larwood Co-Founder & CEO | Funding Raised | — | — | — |
| 8 | PathogenDX Provider of DNA-based pathogen testing kits | $12M | 70 mo ago | 31 31 → 26 (-16%) | Milan Patel CEO and Co-Founder | Series B | WordPressMySQLPHP+35 | 69 patents Nucleic acid amplification and multiplex detection of RNA pathogens | 1 launch |
| 9 | DMetrix Developer of microscopic-imaging instrumentation for telepathology and life science applications | $10M | 156 mo ago | — | Artur Olszak Founder & CEO | Funding Raised | — | 39 patents Advanced optical metrology for non‑spherical surface interferometry and focus prediction | — |
| 10 | Reglagene Developer of drugs for treating cancer | $7M | 25 mo ago | 12 | — | Series A | — | 12 patents Small‑molecule tubulin‑targeted therapeutics for cancer and related health conditions | — |
| 11 | Salutaris Medical Devices Saving vision with precision beta radiotherapy for age-related macular degeneration | $6M | 100 mo ago | 4 | — | Series A | — | — | — |
| 12 | Sentinel Monitoring Systems Online bioburden monitoring tools and instrument platform | $4M | 129 mo ago | 7 | — | Acqui-Hired | — | — | — |
| 13 | Instant BioScan Real-time microbial monitoring systems for liquid contaminant detection and quantification | $3M | 147 mo ago | 16 | — | Acquired | — | 5 patents Rapid point‑of‑care microbial detection devices and methods | — |
| 14 | CATS Developer of intraocular pressure monitoring device | $3M | 15 mo ago | 3 | — | Funding Raised | — | — | — |
| 15 | EnduRx Developer of nanosystem for breast cancer therapy | $3M | 76 mo ago | 3 | — | Funding Raised | — | — | — |
| 16 | ProNeurogen Developer of therapeutics to treat vascular dementia and neuropathic pain | $3M | 33 mo ago | — | Meredith Hay Founder & CEO | Funding Raised | — | 8 patents Peptide therapeutics targeting amyloid imaging and sustained-release angiotensin‑(1‑7) formulations | — |
| 17 | QScint Provider of real-time alpha- and beta-particle imaging systems | $2M | 11 mo ago | — | Brian Miller Founder | Funding Raised | — | — | — |
| 18 | Regulonix Developing non-opioid drugs for treating chronic pain | $2M | 96 mo ago | 1 | Marcel Patek Co-Founder & President | Seed | — | — | — |
| 19 | StimAire Developer of neural stimulation treatment therapy | $2M | 79 mo ago | 5 | Tarek Makansi Founder & CTO | Seed | — | 30 patents Implantable wireless neural stimulators for peripheral nerve therapy and sleep apnea treatment | — |
| 20 | Fibronox Developer of novel treatments for fibrotic diseases | $1M | 25 mo ago | — | Louise Hecker Founder & CSO | Funding Raised | — | — | — |
| 21 | NuvOx Therapeutics Developer of an oxygen therapeutic drug designed to reverse tissue hypoxia | $1M | 14 mo ago | — | Jennifer Johnson Co-Founder & Chief Scientific Officer | Funding Raised | Cart FunctionalityWixSentry+14 | — | — |
| 22 | Emagine Solutions Technology Provider of pregnancy management app and device for women and healthcare providers | $1M | 35 mo ago | 5 | — | Funding Raised | — | — | — |
| 23 | Delta Development Team Manufacturer of ruggedized thermal systems | $960K | 11 mo ago | 19 | William Barg Co-Founder | Series A | WordPress Block EditorWordPress Site EditorElementor+37 | — | 1 launch |
| 24 | GMSbiotech Provider of micro array technologies to bypass DNA purification and quantitation | $837K | 157 mo ago | — | Krishna jayaraman Co-Founder & CEO | Seed | — | — | — |
| 25 | ElectroSonix Manufacturer of imaging diagnostic devices | $640K | 69 mo ago | — | Sonia Vohnout Co-Founder | Deadpooled | — | — | — |
| 26 | PATH Biotech Provider of AI-powered platforms for drug discovery and development | $500K | 40 mo ago | — | Rui Chang Founder & CEO | Funding Raised | — | — | — |
| 27 | MSDx Provider of blood test products for brain diseases | $301K | 124 mo ago | — | Marie Wesselhoft Co-Founder | Deadpooled | — | 22 patents Blood-based phagocyte biomarkers for diagnosing neurodegenerative diseases | — |
| 28 | MediCarbone Developer of polymer implant systems for bone repair | $274K | 33 mo ago | 6 | Hamid Saadatmanesh CEO | Seed | — | 13 patents Intramedullary sleeve devices and biocompatible polymeric resins for bone repair | — |
| 29 | Capienda Biotech Developer of drug delivery technology | $256K | 55 mo ago | 5 | Mark Bernard CEO & President | Funding Raised | — | — | — |
| 30 | Souvie Biodelivery Developer of exosome-based drug delivery technology | $225K | 64 mo ago | 1 | — | Funding Raised | — | — | — |
| 31 | EPV Sensors Developing non-invasive IOP sensing technology for glaucoma detection and home diagnostics | $225K | 132 mo ago | 1 | Gholam Peyman Co-Founder | Funding Raised | — | — | — |
Top 12 Life Sciences companies in Tucson
#1
Funding Raised · Tucson, Arizona · founded 2019$2.4Mraised▾
Provider of real-time alpha- and beta-particle imaging systems. These systems are used for digital autoradiography, radiopharmaceutical development, targeted alpha therapy, radioactivity quality assurance, and geochronology. The systems are lightweight and easy to install, facilitating various research and industrial applications. They enable visualization and capture of digital images showing the spatial distribution of alpha- and beta-emitting radionuclides in diverse samples. The technology also supports applications in screening for alpha-emitting poisons.
- Aug 2025Grant (prize money)$1.6M
- Sep 2024Grant (prize money)$811.5K
#2
Series A · Tucson, Arizona · founded 2018 · 19 employees$960Kraised▾
Manufacturer of ruggedized thermal systems
- Aug 2025Grant (prize money)—
- Aug 2025Series A—
- Dec 2024Series A$357.8K
- Sep 2023Series A$960K
#3
Funding Raised · Tucson, Arizona · founded 2018 · 3 employees$3.4Mraised▾
CATS Tonometer has developed a device for monitoring the intraocular pressure. The products developed is a FDA cleared, patented device called Prism for measuring the IOP used for diagnosing and treating glaucoma and other ocular related diseases.
- Mar 2025Grant (prize money)$1.1M
- Sep 2018Grant (prize money)$1.1M
- Jun 2018Grant (prize money)$1.1M
#4
Funding Raised · Tucson, Arizona · founded 2008$1.4Mraised▾
Developer of an oxygen therapeutic drug designed to reverse tissue hypoxia. The company focuses on developing a drug that improves oxygen flow from lungs to blood and from blood to tissue. Animal studies have demonstrated therapeutic effects across multiple indications. The company's clinical programs include trials for glioblastoma, stroke, and respiratory distress. The therapeutic drug is currently under clinical investigation and not yet approved for general medical use.
- Apr 2025Grant (prize money)$900.4K
- May 2010Grant (prize money)$204.4K
- Dec 2009Grant (prize money)$303.7K
#5
Series A · Tucson, Arizona · founded 2016 · 12 employees$7Mraised▾
Developer of drugs for treating cancer. It offers small-molecule drugs that can cross the blood-brain barrier and targets diseases like glioblastoma (aggressive brain cancer) and metastatic brain tumor. It offers RGN6024 an Oral (pill-based) treatment that enter the brain and attack tumors.
- May 2024Conventional Debt$766.7K
- Dec 2023Series A$5.4M
- May 2023Seed$1.6M
- Jul 2021Seed$600K
#6
Public · Tucson, Arizona · founded 1987 · 197 employees$366.3Mraised▾
Developer of diagnostic devices and test kits for the antibiotic resistant infections. The company's products include Accelerate Pheno system and Accelerate PhenoTest BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the most optimal antibiotic therapy for deadly infections.
- Mar 2021Post IPO$32M
- Aug 2019Post IPO$1000K
- Mar 2018Post IPO$171.5M
- May 2017Post IPO$79.3M
#7
Funding Raised · Tucson, Arizona · founded 2023$1.5Mraised▾
Developer of novel treatments for fibrotic diseases. It develops selective Nox4 inhibitors and Nrf2 activators to mitigate life-threatening fibrotic diseases. Preclinical studies show efficacy in halting and reducing fibrosis. The company focuses on idiopathic pulmonary fibrosis (IPF) initially, with potential applications in other fibrotic indications. An inhaled delivery method is employed for enhanced efficacy and reduced side effects compared to oral administration.
- Jun 2024Grant (prize money)$954.7K
- May 2024Grant (prize money)$286.7K
- Sep 2020Grant (prize money)$248K
#8
Funding Raised · Tucson, Arizona · founded 2013$2.8Mraised▾
Developer of therapeutics to treat vascular dementia and neuropathic pain. The company harnesses the power of peptides, specifically Angiotensin-(1-7) peptides, which are selective Mas receptor agonists. The company has a pipeline of drug candidates targeting various brain disorders, including traumatic brain injury and post-operative cognitive dysfunction.
- Sep 2023Grant (prize money)$499.5K
- Sep 2022Grant (prize money)$499.8K
- Sep 2022Grant (prize money)$499.2K
- Aug 2020Grant (prize money)$439.4K
#9
Public · Tucson, Arizona · founded 1997 · 47 employees$47.3Mraised▾
Developer of diagnostics and targeted therapeutics across a variety of disease areas. The company is a leading provider of molecular-based technology solutions for gene expression profiling, miRNA, siRNA, and mRNA measurement for translational medicine and diagnostic applications. Their automated HTG Edge platform is designed to quickly and simultaneously profile thousands of clinically relevant molecular targets from samples a fraction of the size required by current technologies. Also offers services (VERI/O Laboratory Services ) such as retrospective sample processing, pilot studies, custom assay development, disease-specific validation studies, and molecular profiling studies
- Jun 2020Post IPO$3M
- Sep 2019Post IPO$3.5M
- Jan 2018Post IPO$2.2M
- Aug 2014Conventional Debt$16M
#10
Funding Raised · Tucson, Arizona · founded 2007 · 9 employees$13.2Mraised▾
Luceome Biotechnologies is a drug discovery company focused on developing its assay technology for the identification of drugs against kinases. It provides unique assay solutions (KinaseSeeker and KinaseLite) which are based on a technology platform that utilizes luciferase fragment complementation and the resulting luminescence allows the identification of the target and off-target effects of drug candidates.
- Apr 2022Grant (prize money)$240.4K
- Dec 2019Grant (prize money)$1.8M
- Mar 2019Grant (prize money)$2.2M
- Sep 2014Grant (prize money)$240K
#11
Acquired · Tucson, Arizona · founded 2008 · 14 employees$16.3Mraised▾
Your trusted source for health education, tips, and guidance. We provide valuable information and resources on various health topics, including healthy eating, disease prevention, and lifestyle improvements. Our platform offers guidance and practical tips to empower individuals to make informed decisions about their well-being. We focus on delivering accessible and reliable content to promote a healthier lifestyle. We cover diverse subjects such as nutrition, fitness, and mental health, aiming to be a comprehensive resource for health-conscious individuals. We are committed to providing educational content that supports a proactive approach to health management.
- Jan 2021Conventional Debt$400K
- Sep 2017Series B$9.5M
- Apr 2017Series A$700K
- Jan 2016Conventional Debt$835K
#12
Acquired · Tucson, Arizona · founded 1999$76.1Mraised▾
Developer and manufacturer of In-Vitro Diagnostics for the early detection and diagnosis of cervical and other cancers. The company markets its proprietary CINtec(R) Histology Kit and CINtec(R) Cytology Kit as adjunct tools for the early detection and diagnosis of cervical cancer.
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in the United States
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 6,260 United States-affiliated papers.
- Harvard University209
- Cornell University177
- University of Tennessee at Chattanooga140
- Howard Hughes Medical Institute126
- Johns Hopkins University121
- Gene33→164
- Transcription (linguistics)11→79
- Antibody11→62
- Genome6→56
- Mutation7→56
- Gene8→110
- Cell culture3→62
- Gene expression3→62
- Fermentation2→54
- Downregulation and upregulation1→50
- Agriculture19→58
- Antibiotic resistance15→45
- Public health4→31
- Gene6→30
- Production (economics)5→29
Where biotechnology is researched across United States
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Who's filing biotechnology patents in the United States
United States biotechnology patent filing is accelerating — 457,918 filings from 8,000 assignees (2016–2025), led by Genentech, UNIV California, Regeneron Pharma; annual filings 36884→44446.
- Genentech18113
- UNIV California17975
- Regeneron Pharma16083
- Amgen10515
- Monsanto Technology9755
- UNIV Pennsylvania8528
- Harvard College7464
- UNIV Texas7384
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.